Rein Therapeutics (formerly Lung Therapeutics) is a clinical-stage biopharmaceutical company developing novel therapies for orphan pulmonary and fibrosis indications. Its lead candidate, LTI-03, is an inhaled peptide derived from the Cav1 protein in Phase 2 development for Idiopathic Pulmonary Fibrosis (IPF). LTI-01, a proenzyme for loculated pleural effusion, has been paused indefinitely. The company also has paused preclinical programs in cystic fibrosis and systemic fibrosis.
Q2 FY2026 — expected 2026-09-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001193125-26-126385 | EDGAR | 98K words |
| 2025-04-07 | 2024-12-31 | 0000950170-25-051566 | EDGAR | 113K words |
| 2024-04-15 | 2023-12-31 | 0000950170-24-044508 | EDGAR | 104K words |
| 2023-03-20 | 2022-12-31 | 0000950170-23-008767 | EDGAR | 84K words |
| 2022-03-28 | 2021-12-31 | 0000950170-22-004774 | EDGAR | — |
| 2021-03-24 | 2020-12-31 | 0001564590-21-015115 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001564590-20-014155 | EDGAR | — |
| 2019-03-29 | 2018-12-31 | 0001564590-19-010007 | EDGAR | — |
| 2018-04-02 | 2017-12-31 | 0001564590-18-007403 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001193125-26-350270 | EDGAR | 25K words |
| 2025-11-14 | 2025-09-30 | 0001193125-25-281622 | EDGAR | 31K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-108836 | EDGAR | 29K words |
| 2025-05-15 | 2025-03-31 | 0000950170-25-072607 | EDGAR | 23K words |
| 2024-11-14 | 2024-09-30 | 0000950170-24-127019 | EDGAR | 26K words |
| 2024-08-14 | 2024-06-30 | 0000950170-24-097199 | EDGAR | 24K words |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060583 | EDGAR | 22K words |
| 2023-10-13 | 2023-09-30 | 0000950170-23-053302 | EDGAR | 19K words |
| 2023-08-11 | 2023-06-30 | 0000950170-23-041839 | EDGAR | 19K words |
| 2023-05-08 | 2023-03-31 | 0000950170-23-018476 | EDGAR | 18K words |
| 2022-11-01 | 2022-09-30 | 0000950170-22-020709 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0000950170-22-017372 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-04 | 0001193125-26-383726 | EDGAR | 4K words |
| 2026-08-27 | 0001193125-26-371260 | EDGAR | 1K words |
| 2026-07-21 | 0001193125-26-310315 | EDGAR | 1K words |
| 2026-03-02 | 0001193125-26-084012 | EDGAR | 15K words |
| 2026-02-19 | 0001193125-26-059545 | EDGAR | 0K words |
| 2026-01-16 | 0001193125-26-015524 | EDGAR | 15K words |
| 2025-12-11 | 0001193125-25-316225 | EDGAR | 1K words |
| 2025-11-03 | 0001193125-25-261706 | EDGAR | 1K words |
| 2025-10-24 | 0001193125-25-250175 | EDGAR | 1K words |
| 2025-10-09 | 0001193125-25-235152 | EDGAR | 1K words |
164 total filings indexed. 133 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001420565 |
| Ticker | RNTX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Website | https://www.reintx.com |
| Listed | 2017-06-29 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/RNTX (~200 tokens, structured JSON with cryptographic provenance)